BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2081494)

  • 1. Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function.
    Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
    Drugs; 1990; 40 Suppl 5():53-6. PubMed ID: 2081494
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function.
    Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
    Br J Rheumatol; 1990 Apr; 29(2):116-9. PubMed ID: 2108782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?
    Dandona P; Jeremy JY
    Drugs; 1990; 40 Suppl 5():16-24. PubMed ID: 2081487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
    Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
    Melarange R; Spangler R; Hoult JR
    Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
    Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
    Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
    Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
    Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
    Melarange R; Rashbrook LC
    J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
    Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
    Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nabumetone and indomethacin on gastric mucosal function.
    Shorrock CJ; Rees WD
    J Rheumatol Suppl; 1992 Nov; 36():85-8. PubMed ID: 1474543
    [No Abstract]   [Full Text] [Related]  

  • 11. Low direct cytotoxicity of nabumetone on gastric mucosal cells.
    Arai Y; Tanaka K; Ushijima H; Tomisato W; Tsutsumi S; Aburaya M; Hoshino T; Yokomizo K; Suzuki K; Katsu T; Tsuchiya T; Mizushima T
    Dig Dis Sci; 2005 Sep; 50(9):1641-6. PubMed ID: 16133963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen.
    Gund M; Gaikwad P; Borhade N; Burhan A; Desai DC; Sharma A; Dhiman M; Patil M; Sheikh J; Thakre G; Tipparam SG; Sharma S; Nemmani KVS; Satyam A
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5587-5592. PubMed ID: 25466180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolac.
    Melarange R; Gentry C; Durie M; O'Connell C; Blower PR
    Dig Dis Sci; 1994 Mar; 39(3):601-8. PubMed ID: 8131699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel acylindole derivative on experimental thrombotic models, ulceration of the gastric mucosa and prostacyclin production in the aorta.
    Ohtsu A; Oba T; Kamimoto F; Wada H; Hoshina K; Saitoh N; Okada N; Yamazaki N; Kurozumi S; Naruchi T
    Thromb Res; 1981 Nov; 24(3):233-44. PubMed ID: 7038975
    [No Abstract]   [Full Text] [Related]  

  • 15. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
    Boyle EA; Freeman PC; Mangan FR; Thomson MJ
    J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.
    Nobilis M; Mikušek J; Szotáková B; Jirásko R; Holčapek M; Chamseddin C; Jira T; Kučera R; Kuneš J; Pour M
    J Pharm Biomed Anal; 2013 Jun; 80():164-72. PubMed ID: 23584048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humans.
    Brett MA; Buscher G; Ellrich E; Greb WH; Kurth HJ; Rülander G; Schmerenbeck B; Haddock RE; Thawley AR
    Drugs; 1990; 40 Suppl 5():67-70. PubMed ID: 2081498
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
    Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
    J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions.
    Ishiwata Y; Okamoto M; Yokochi S; Hashimoto H; Nakamura T; Miyachi A; Naito Y; Yoshikawa T
    J Pharm Pharmacol; 2003 Feb; 55(2):229-37. PubMed ID: 12635655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.